New Key Statistics Module, Z-Score and F-Score
NAS:PLRX Key Ratios
| Market Cap $ M | 716.59 |
| Enterprise Value $ M | 234.92 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.50 |
| Price/Sales | 425.73 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -2.76 |
| Beneish M-Score | 0.42 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -84.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.47 |
| EV-to-EBITDA | -1.48 |
| PEG | -- |
| Shares Outstanding M | 60.32 |
| Net Margin (%) | -10,211.14 |
| Operating Margin % | -11,654.75 |
| Pre-tax Margin (%) | -10,211.14 |
| Quick Ratio | 17.72 |
| Current Ratio | 17.72 |
| ROA % (ttm) | -31.32 |
| ROE % (ttm) | -33.82 |
| ROIC % (ttm) | -1,089.73 |
| Dividend Yield % | -- |
| Altman Z-Score | 9.89 |
PLRX Number of Guru Trades
PLRX Volume of Guru Trades
Gurus Latest Trades with NAS:PLRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PLRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pliant Therapeutics Inc Insider Transactions
No Available Data
News about NAS:PLRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers